🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is evaluating the Pharmacokinetics of MNTX in healthy control su...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2004-03
Trial ID
NCT01367509
Treatments Being Tested
This study is designed to evaluate the long-term safety and tolerability of...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-12-03
Trial ID
NCT00804141
Treatments Being Tested
To determine the efficacy of subcutaneous MNTX to relieve opioid-induced co...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2004-02
Trial ID
NCT00402038
Treatments Being Tested
To learn if OCSCC patients can be safely given methylnaltrexone for 2 weeks...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-01-10
Trial ID
NCT06162377
Treatments Being Tested
To test the effectiveness of MNTX in advanced illness subjects....
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2003-02
Trial ID
NCT00401362
Treatments Being Tested
This is a 3 month open-label extension study that allows patients who compl...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2004-03
Trial ID
NCT01367613
Treatments Being Tested
This is an open label compassionate use study of subcutaneously administere...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2003-01-24
Trial ID
NCT01368562
Treatments Being Tested
The purpose of this study is to describe the effects of methylnaltrexone in...
Status
Completed
Location
Department of Clinical Pharmacology, Ernst-Moritz-Arndt-University Greifswald
Start Date
2010-01
Trial ID
NCT01596777
This study is an open-label extension allowing patients who have completed ...
Status
Completed
Location
Progenics Pharmaceuticals
Start Date
2003-02
Trial ID
NCT01367600
Treatments Being Tested
This is a multicenter, non-randomized, single-dose, parallel-group study. E...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2004-03
Trial ID
NCT01367522
Treatments Being Tested